Cassava Sciences Inc (SAVA)
26.12
+0.92
(+3.65%)
USD |
NASDAQ |
Nov 14, 16:00
26.09
-0.03
(-0.11%)
After-Hours: 20:00
Cassava Sciences Total Return Level: 42.60 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 42.60 |
November 12, 2024 | 44.60 |
November 11, 2024 | 45.74 |
November 08, 2024 | 45.56 |
November 07, 2024 | 42.84 |
November 06, 2024 | 44.92 |
November 05, 2024 | 40.45 |
November 04, 2024 | 43.68 |
November 01, 2024 | 44.31 |
October 31, 2024 | 43.62 |
October 30, 2024 | 43.95 |
October 29, 2024 | 44.83 |
October 28, 2024 | 45.19 |
October 25, 2024 | 44.88 |
October 24, 2024 | 46.13 |
October 23, 2024 | 47.32 |
October 22, 2024 | 48.06 |
October 21, 2024 | 48.82 |
October 18, 2024 | 49.02 |
October 17, 2024 | 50.00 |
October 16, 2024 | 50.09 |
October 15, 2024 | 47.77 |
October 14, 2024 | 46.49 |
October 11, 2024 | 43.61 |
October 10, 2024 | 42.03 |
Date | Value |
---|---|
October 09, 2024 | 42.26 |
October 08, 2024 | 44.04 |
October 07, 2024 | 42.96 |
October 04, 2024 | 45.78 |
October 03, 2024 | 45.58 |
October 02, 2024 | 45.54 |
October 01, 2024 | 46.35 |
September 30, 2024 | 49.75 |
September 27, 2024 | 48.15 |
September 26, 2024 | 53.88 |
September 25, 2024 | 51.51 |
September 24, 2024 | 50.00 |
September 23, 2024 | 45.65 |
September 20, 2024 | 50.34 |
September 19, 2024 | 51.32 |
September 18, 2024 | 51.26 |
September 17, 2024 | 52.91 |
September 16, 2024 | 47.91 |
September 13, 2024 | 47.54 |
September 12, 2024 | 47.76 |
September 11, 2024 | 46.20 |
September 10, 2024 | 45.64 |
September 09, 2024 | 45.53 |
September 06, 2024 | 45.49 |
September 05, 2024 | 49.79 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.094
Minimum
Nov 18 2019
228.72
Maximum
Jul 28 2021
47.25
Average
40.56
Median
Jan 09 2024
Total Return Level Benchmarks
Bristol-Myers Squibb Co | 239.89 |
Seelos Therapeutics Inc | 0.70 |
EyePoint Pharmaceuticals Inc | 10.75 |
PTC Therapeutics Inc | 44.05 |
Adverum Biotechnologies Inc | 7.57 |